PROVO, Utah--(BUSINESS WIRE)--GeNOsys (generated nitric oxide systems) Inc., (OTCBB:GNYS), a medical research and development company specializing in pharmaceutical, biotechnical and medical gas generating systems, announces that Mr. Michael J. Holman has agreed to join the Company as its new Chief Financial Officer.
